Breaking News: Pyramax Patented for Treating Multiple Viral Infections
In a groundbreaking development, Shin Poong Pharmaceutical has announced that its drug Pyramax has been granted a new patent by the European Patent Office (EPO) for its effectiveness in treating and preventing a variety of viral infections. This news is set to have a significant impact on global public health and could revolutionize the treatment of infectious diseases.
New Patent Covers Broad Spectrum of Viral Infections
According to a statement from Shin Poong Pharmaceutical, the new patent covers the pharmaceutical composition of Pyramax, which includes almicinin derivatives, althemiin derivatives, and their combinations. This patent specifically recognizes Pyramax’s ability to treat and prevent pandemic RNA virus infectious diseases such as COVID-19, Severe Acute Respiratory Syndrome (SARS), and Middle East Respiratory Syndrome (MERS).
Global Recognition and Patent Registrations
The company has already completed patent registrations for the same composition in China for COVID-19 and MERS infections in March 2023. Furthermore, in July 2023, 17 countries under the African Intellectual Property Organization (OAPI) registered the same composition patent for epidemic RNA virus infections. This global recognition underscores the significance of Pyramax in the fight against viral outbreaks.
CEO’s Perspective on the Achievement
Yu Je-man, CEO of Shin Poong Pharmaceutical, expressed his enthusiasm about this achievement, stating, “This recognition of Pyramax’s newness and progress in treating corona diseases is a significant milestone for us.”
Evergreen Context: The Evolution of Antiviral Treatments
The development of antivirals like Pyramax is part of a long history of scientific advancements in combating infectious diseases. From the early days of antiviral research to the current era of rapid genetic sequencing and drug development, the fight against viruses has evolved significantly. This new patent is a testament to the ongoing efforts to stay ahead of emerging viral threats and provide effective treatments.
For those interested in staying updated on the latest developments in antiviral treatments and global health news, archyde.com is your go-to source for breaking news and in-depth analysis. Bookmark our site and follow us on social media for real-time updates and expert insights.
With this new patent, Pyramax is poised to play a crucial role in the global fight against viral infections. As we continue to monitor the situation, archyde.com will keep you informed about the latest advancements and their implications for public health.
Stay tuned to archyde.com for more breaking news and updates on this developing story.
